Indivior wins preliminary injunction against generic rival

A U.S. court has granted Indivior a preliminary injunction blocking India’s Dr. Reddy’s Laboratories from selling cut-price versions of the British drugmaker’s best-selling opioid addiction treatment in the United States, Indivior said on Friday.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *